Huge thanks to patient orgs like @netrf.org and @inca-netcancerday.bsky.social for their incredible work driving #patient awareness of trials!

We must ensure their efforts don't go unanswered.

#ClinicalTrials #DigitalHealth #PatientAdvocacy #patientrecruitment #healthequity

The challenge isn't lack of interest; it's a breakdown in execution. We must do better.

📣Call to Action for Sponsors, Sites & Research Institutions:

We need to redesign & modernize patient recruitment pathways. Let's work together to fix this systemic leak & ensure every patient connection counts.

This isn't just a #NET issue- across 17 countries (2021-24):

📈 High Interest: 91% of cancer patients want to participate (CISCRP).

📉 Severe Leak: Only 20% of interested cancer patients actually get the timely, actionable info needed for a referral.

#patientrecruitment #clinicaltrials

🚨 The Leak is REAL.

Our analysis showed a staggering 78% of patient trial requests received NO response from sites OR were for trials that were already closed.

We called this the "Last Mile Leak" with Ken Getz from Tufts CSDD: bit.ly/3KnXcNm

#patientrecruitment #clinicaltrials

And a huge thank you for the opportunity to showcase our poster on how ancora.ai's tech can effectively identify #clinicaltrials for #CUP patients & expand treatment options.
Congratulations to the World CUP Alliance on a successful inaugural event & a great kick off to
@myesmo.bsky.social

There were many discussions on:
-better segmenting #CUP patients
-quickly & effectively identifying a primary to get to targeted therapies
-challenges of accessing targeted therapies

The future lies in multi-omics, adv. imaging (incl. #radiopharmaceuticals), liquid biopsies & global collaboration.

Please reach out if you'd like to learn more or help us amplify this important resource for patients and their care teams.

#cancerresearch #clinicaltrials #cancer #braincancer #GBM #gliomas #meningioma #medulloblastoma

A heartfelt thank you to our users for your engagement and feedback. In just 6 months we've had users from 28 countries use our radtrials.com tool!

Next up: We're looking forward to #ASCO2025 and #SNMMI2025 so please be sure to say hello!

#clinicaltrials #cancerresearch #Cansky #Oncsky #Medsky

#ICPO2025 brought together leading minds from across the world, sparking insightful discussions around the implementation & personalization of #radiopharamceuticals in #cancer.

And if you haven't heard of radiopharmaceuticals or #nuclearmedicine, be sure to check out @nucmed-patients.bsky.social

❤️